海峡药学
海峽藥學
해협약학
STRAIT PHARMACEUTICAL JOURNAL
2015年
4期
249-251
,共3页
缪世峰%蔺宇%张海波%梁慧兴%陈令武
繆世峰%藺宇%張海波%樑慧興%陳令武
무세봉%린우%장해파%량혜흥%진령무
化学合成%替格瑞洛%抗凝血药
化學閤成%替格瑞洛%抗凝血藥
화학합성%체격서락%항응혈약
Chemical synthesis%Ticagrelor%Anticoagulant
目的:高效合成抗凝血药替格瑞洛。方法4,6-二氯-2-(丙硫基)-5-硝基嘧啶在铁粉、乙酸作用下还原后与2-(((3aR,4S,6R,6aS)-6-氨基-2,2-二甲基四氢-3aH-环戊〔d〕〔1,3〕二氧杂-4-基)氧基)乙醇经C-N偶联、重氮化成环,再与(1R,2R)-2-(3,4-二氟苯基)环丙胺亲核取代,最后酸解脱丙叉基保护得到替格瑞洛。结果与结论目标化合物的总收率约为55%,结构经1 H NMR和 MS确证。该合成路线反应步骤少,操作简便,反应条件温和,收率高,适合工业化生产。
目的:高效閤成抗凝血藥替格瑞洛。方法4,6-二氯-2-(丙硫基)-5-硝基嘧啶在鐵粉、乙痠作用下還原後與2-(((3aR,4S,6R,6aS)-6-氨基-2,2-二甲基四氫-3aH-環戊〔d〕〔1,3〕二氧雜-4-基)氧基)乙醇經C-N偶聯、重氮化成環,再與(1R,2R)-2-(3,4-二氟苯基)環丙胺親覈取代,最後痠解脫丙扠基保護得到替格瑞洛。結果與結論目標化閤物的總收率約為55%,結構經1 H NMR和 MS確證。該閤成路線反應步驟少,操作簡便,反應條件溫和,收率高,適閤工業化生產。
목적:고효합성항응혈약체격서락。방법4,6-이록-2-(병류기)-5-초기밀정재철분、을산작용하환원후여2-(((3aR,4S,6R,6aS)-6-안기-2,2-이갑기사경-3aH-배무〔d〕〔1,3〕이양잡-4-기)양기)을순경C-N우련、중담화성배,재여(1R,2R)-2-(3,4-이불분기)배병알친핵취대,최후산해탈병차기보호득도체격서락。결과여결론목표화합물적총수솔약위55%,결구경1 H NMR화 MS학증。해합성로선반응보취소,조작간편,반응조건온화,수솔고,괄합공업화생산。
OBJECTIVE To Develop a highly-efficient synthesis method for anticoagulant ti-cagrelor.METHODS 4,6-Dichloro-2-(propylthio)pyrimidin-5-aminewasreducedintoaminocompoundviairon powder and acetic acid,and after the C-N cross-coupling and diazotization into the ring with 2-(((3aR,4S,6R, 6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta〔d〕〔1,3〕dioxol-4-yl) oxy) ethanol,which was followed by nu-cleophilic substitution with (1R,2R)-2-(3,4-difluoro) cyclopropanamine and isopropylidene deprotection to provide ticagrelor.RESULTS and CONCLUSION The target compound was obtained in about 55%overall yield,and the chemical structure was confirmed by 1H NMR and MS.The developed method has some advantages such as few reac-tion steps,ease operations,mild reaction conditions,high yield,and suitable for industrial production.